What is the equity of Xencor this year?
Xencor has equity of 677.61 M USD this year.
Xencor Equity 2025
Xencor Equity
677.61 M USD
Ticker
XNCR
ISIN
US98401F1057
WKN
A1W96L
In 2025, Xencor's equity was 677.61 M USD, a 2.4% increase from the 661.75 M USD equity in the previous year.
Xencor Aktienanalyse
What does Xencor do?
The company Xencor Inc was founded in 1997 and has since become a significant biotechnology company specializing in the development of therapeutic proteins. Xencor's goal is to develop innovative and tailored therapies for the treatment of serious diseases such as cancer and autoimmune diseases. The company is headquartered in Monrovia, California, and employs a growing number of scientists, engineers, and other professionals specialized in the development of new themes and products. Xencor has acquired a variety of patents over the years to protect its intellectual property. Its business model is based on the development of new therapeutics through its proprietary XmAb technology platform, which enables the production of highly specific polyclonal antibodies that can improve the efficiency and safety of disease treatments. Xencor has divided its business activities into various divisions, including the development of immuno-oncology products, autoimmune therapies, and new methods for the therapy of inflammatory bowel diseases. The company has developed a wide range of products, including a new class of therapeutic antibodies that mobilize and strengthen patients' own immune system to fight cancer cells. By combining these antibodies with other therapies, the effectiveness of the treatment can be further increased. In the autoimmune diseases division, Xencor has developed new therapeutics to better regulate patients' immune system and treat dangerous autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, or lupus. Another focus of the company is the development of therapies for inflammatory bowel diseases such as ulcerative colitis or Crohn's disease. By developing specific antibodies involved in the inflammatory processes in the intestine, Xencor can contribute to improving the treatment of these conditions. Xencor aims to accelerate the development of new therapeutics while improving their efficacy and safety. With the help of its proprietary XmAb technology platform, the company is able to develop new drugs faster and more effectively than conventional methods. Through the combination of technology, research and development, and a high level of commitment, Xencor pursues its vision and has successfully established itself as one of the leading companies in the biotechnology industry. Xencor ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Xencor's Equity
Xencor's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Xencor's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Xencor's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Xencor's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Xencor’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Xencor stock
What was the equity of Xencor compared to the previous year?
The equity of Xencor has increased/decreased by 2.4% increased compared to the previous year.
What impact does a high equity have on investors of Xencor?
A high equity is advantageous for investors of Xencor as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Xencor?
A low equity can be a risk for investors of Xencor, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Xencor affect the company?
An increase in equity of Xencor can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Xencor affect the company?
A reduction in equity of Xencor can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Xencor?
Some factors that can affect the equity of Xencor include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Xencor so important for investors?
The equity of Xencor is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Xencor take to change the equity?
To change equity, Xencor can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Xencor pay?
Over the past 12 months, Xencor paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xencor is expected to pay a dividend of 0 USD.
What is the dividend yield of Xencor?
The current dividend yield of Xencor is .
When does Xencor pay dividends?
Xencor pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Xencor?
Xencor paid dividends every year for the past 0 years.
What is the dividend of Xencor?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Xencor located?
Xencor is assigned to the 'Health' sector.
Wann musste ich die Aktien von Xencor kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Xencor from 9/27/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2025.
When did Xencor pay the last dividend?
The last dividend was paid out on 9/27/2025.
What was the dividend of Xencor in the year 2024?
In the year 2024, Xencor distributed 0 USD as dividends.
In which currency does Xencor pay out the dividend?
The dividends of Xencor are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Xencor stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Xencor
Our stock analysis for Xencor Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xencor Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
